Description: As more gene and cell therapies enter the market at increasingly higher price points, they are ushering in a new era of medicine for rare diseases. Unlike most traditional therapies, gene and cell therapies typically have a short or one-time treatment administration and are anticipated to provide long-term clinical benefits. Actuaries must be prepared to assess, manage, and/or mitigate the risks associated with these therapies. This session includes three different perspectives—a regional plan, a stop loss/reinsurance carrier, and a health care consultant.

Description: The U.S. life insurance industry has been increasing its exposure to complex assets, either directly as investors or via offshore reinsurance (e.g., Bermuda). In order to address regulatory concerns about such investments and reinsurance arrangements, the NAIC has begun multiple initiatives to improve disclosure and strengthen regulatory requirements, and the Bermuda Monetary Authority is also strengthening its requirements. Hear a summary of these initiatives, and get an update on the latest developments at the NAIC and at the Academy on these topics.

Description: This session will summarize the key National Association of Insurance Commissioners (NAIC) activities with a primary focus on updates to principle-based reserve valuations and appointed actuary topics. Hear insights into the current set of activities and initiatives being considered and/or adopted by the NAIC Life Actuarial Task Force (LATF) and the NAIC Risk Based Capital Working Group.

Description: Given the rise in interest rates during 2023, the session will discuss the implication of increasing rates on FA and FIA business by looking at industry experience for FA and FIA products for 2023 and earlier years. Additionally, the session will walk through partial withdrawals, GLWB utilization, mortality and what to expect as interest rates volatile continues. The session will also discuss how direct writers and reinsurers are handing the inforce management aspects of these products in the uncertain and volatile economic periods.

Description: Explore various aspects of the Asian reinsurance market in this webcast. Learn about the landscape within the market as speakers cover key topics like product perspectives, structured solutions and emerging trends and issues. Take an in-depth look at the post COVID-19 impact, as well as regulatory considerations that could affect the Asian reinsurance industry. Secure your spot in this opportunity and dive into the direction of this marketspace.

Description: Experts from both the direct and reinsurance side of the table will provide an overview of final expense products and their key features, as well as share experiences that have informed best practices when designing, selling, managing, monitoring and reinsuring these products. Trends in distribution, underwriting tools and other competitive factors will be considered through the lens of managing risk while remaining competitive in the market.

Description: There is a clear consumer need for long-term care (LTC) coverage. Combo life/LTC products sought to meet that need when stand-alone LTC coverages became more difficult and more expensive to get. Combo life/LTC are built to be more sustainable, allowing for more alignment of interests between the policyholder and insurer. However, combo life/LTC are typically on a universa life (UL) chassis with extensive secondary guarantees, and several were withdrawn from the market in the recent past because of very low interest rates. A couple of carriers have used the variable UL chassis which are still in market. Interest rates have also risen dramatically. The opportunity may be present for innovation in this area that leads to sustainable products. Join the conversation as experts in this area discuss the strengths, weaknesses, opportunities and threats in developing and marketing these products.

Description: Hear diverse perspectives from both a reinsurer and carrier on how to best structure financial reinsurance transactions. Join us as we consider various ceding company objectives as well as impacts from the dynamic economic and regulatory environment. By attending this session, you will be able to: - Better understand common reinsurance transactions - Evaluate whether reinsurance transactions can help you meet your company's objectives and challenges - Gain an appreciation for the ever-changing economic and regulatory environment

Description: Mortality improvement for the U.S. general population has stagnated in recent years and then further deteriorated with the COVID-19 pandemic. However, mortality improvement by socioeconomic factors such as education and income has varied widely during this time period. Explore with us cause-of-death mortality rate trends as well as overall mortality improvement trends by different socioeconomic factors. Join a discussion on approaches that companies can take to proxy the insured population by applying socioeconomic factors to the general population with the goal of better understanding future mortality trends for the insured population.

Description: Come experience an informative and invigorating webcast focused on an overview of the reinsurance market. Discover the opportunities and challenges that this market can create and how to best understand them. You can also expect investment within the reinsurance market to be a particular highlighted topic. Explore an overview of key components of asset strategies and develop a knowledge base on how to fully comprehend and shape the reinsurance business. If you're ready to elevate your understanding of reinsurance, then tune in to this webcast.